Overall Technical outlook

Price Summary

On 2026-04-30, Mankind Pharma Limited's stock began at 2250.0, peaked at 2266.8, declined to 2217.0, and ended the day -0.15% down at 2246.7, with 187557 shares traded.
Over the course of 52 weeks, the stock peaked at 2696.5 and hit a low of 1927.4.
19 analysts suggest that MANKIND's future price will lie between 1990.0 and 3100.0, with an average expected price of roughly 2507.7368.

Technicals

Support and Resistance: The price currently sits at 2246.7, finding support at 2193.3 and resistance at 2270.0. These levels define a range for Mankind Pharma Limited where the price may move, with 2193.3 offering a base and 2270.0 limiting upward momentum.
MANKIND supportResistance 6fd026
Support/Resistance for MANKIND


Aroon: The AROON is in a neutral stance for MANKIND, not indicating a clear upward or downward trend. This suggests a period of market indecision, where neither bulls nor bears have the upper hand.
MANKIND aroon 6fd026
Aroon chart for Mankind Pharma Limited


Bol. Bands: The BOLL BANDS is showing a neutral reading, with no clear direction indicated for upward or downward movement. This neutral position suggests a possible period of consolidation.
MANKIND bbands 6fd026
Bolinger Bands chart for Mankind Pharma Limited


Parabolic SAR: The PSAR continues to indicate a bullish outlook, establishing a key support level that could sustain the market's upward trend. This support suggests that the bullish momentum is likely to persist, offering a foundation for further growth.
MANKIND psar 6fd026
Parabolic Stop and Reverse chart for Mankind Pharma Limited


Stochastic: The STOCHASTIC is in a neutral stance, with no clear direction indicated for the market. This lack of clarity suggests that the market may be in a state of equilibrium for MANKIND, with no strong trend emerging.
MANKIND stoch 6fd026
Stochastic chart for Mankind Pharma Limited


Tripple Moving Agerage: The current state of the Tripple MOVING AVG is neutral, with no clear trend direction indicated. This lack of directional bias suggests that the market may be in a phase of consolidation or uncertainty.
MANKIND trippleSMA 6fd026
Tripple SMA chart for Mankind Pharma Limited


The technical analysis of a company's stock performance is valuable, but only when considered in conjunction with the company's fundamentals. These fundamentals, including financial strength, earnings growth, and leadership, provide a foundation for understanding market movements. Additionally, industry trends and competitive pressures play an important role. By integrating both fundamental and technical analysis, one can better evaluate the company's true potential and make more informed investment decisions.